Bi20 antibody: Clinical Trials

1 trial of Bi20 antibody, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

1 withdrawn. 1 Phase 1, 1 Phase 2.

By phase and status

PhaseTrialsStatus
Phase 11Withdrawn 1
Phase 21Withdrawn 1

Follow Bi20 antibody: new trials by email Literature Review of Bi20 antibody trials Research Report on Bi20 antibody

Trials newest first · largest first

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Study of the Trifunctional Antibody FBTA05 and Donor Lymphocyte Infusion in B-cell Lymphoma After Allogeneic Stem Cell Transplantation
FBTA05 - Leukemia, Stem Cell Transplantation
Phase 1 / Phase 2WithdrawnTechnical University of Munich2010-08-012022-12-07

Conditions studied

Leukemia (1)  ·  Lymphoma, Non-Hodgkin (1)

Sponsors

Technical University of Munich (1)

Countries

Germany (1)

Results publications

PMID 23815981, PMID 34515338